{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T09:13:09Z","timestamp":1791364389145,"version":"4.3.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jtha.2023.11.017","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T20:17:21Z","timestamp":1701893841000},"page":"749-764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Management of catheter-related upper extremity deep vein thrombosis in patients with cancer: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"22","author":[{"given":"Tzu-Fei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Carrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Delluc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2023.11.017_bib1","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.2020007338","article-title":"Venous thromboembolism in cancer patients: a population-based cohort study","volume":"137","author":"Mulder","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.11.017_bib2","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1056\/NEJMra011883","article-title":"Preventing complications of central venous catheterization","volume":"348","author":"McGee","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.11.017_bib3","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMc1408861","article-title":"Anticoagulation for central venous catheters in patients with cancer","volume":"371","author":"D'Ambrosio","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jtha.2023.11.017_bib4","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/jth.15614","article-title":"Anticoagulant treatment for upper extremity deep vein thrombosis: a systematic review and meta-analysis","volume":"20","author":"Valeriani","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.11.017_bib6","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2023.11.017_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1378\/chest.07-1432","article-title":"Clinical outcome of patients with upper-extremity deep vein thrombosis: results from the RIETE Registry","volume":"133","author":"Munoz","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2023.11.017_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12761","article-title":"Characteristics and predictors of venous thrombosis recurrence in patients with cancer and catheter-related thrombosis","volume":"6","author":"Lipe","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.11.017_bib9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/MBC.0000000000001122","article-title":"A\u00a0prospective cohort study of catheter-related thrombosis in cancer patients treated with 1 month of anticoagulation after catheter removal","volume":"33","author":"Baumann Kreuziger","year":"2022","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.jtha.2023.11.017_bib10","first-page":"11","article-title":"Duration of anticoagulation for upper extremity deep vein thrombosis associated with cancer and central venous catheter: outcome of a cohort study","volume":"47","author":"Turrian","year":"2022","journal-title":"J\u00a0Med Vasc"},{"key":"10.1016\/j.jtha.2023.11.017_bib11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.thromres.2014.11.020","article-title":"Outcome of central venous catheter associated upper extremity deep vein thrombosis in cancer patients","volume":"135","author":"Delluc","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.11.017_bib12","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1177\/1076029618788177","article-title":"Clinical course and complications of catheter and non-catheter-related upper extremity deep vein thrombosis in patients with cancer","volume":"24","author":"Mansour","year":"2018","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2023.11.017_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1177\/107602969900500106","article-title":"Regional thrombolysis with urokinase for central venous catheter-related thrombosis in patients undergoing high-dose chemotherapy with autologous blood stem cell rescue","volume":"5","author":"Schindler","year":"1999","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jtha.2023.11.017_bib14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1023\/A:1026503526188","article-title":"The treatment and outcome of cancer patients with thromboses on central venous catheters","volume":"10","author":"Frank","year":"2000","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2023.11.017_bib15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0090-8258(03)00074-X","article-title":"Upper extremity deep vein thrombosis associated with indwelling peripheral venous catheters in gynecology oncology patients","volume":"89","author":"Schimp","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.jtha.2023.11.017_bib16","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1200\/JCO.2005.03.5600","article-title":"Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer","volume":"24","author":"Lee","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtha.2023.11.017_bib17","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1111\/j.1538-7836.2007.02613.x","article-title":"A\u00a0pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study)","volume":"5","author":"Kovacs","year":"2007","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.11.017_bib18","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3109\/10428194.2010.481065","article-title":"Deep venous thromboses in patients with hematological malignancies after peripherally inserted central venous catheters","volume":"51","author":"Tran","year":"2010","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtha.2023.11.017_bib19","first-page":"53","article-title":"Duration of anticoagulation treatment for catheter related thrombosis in hematologic malignancy","volume":"12","author":"Baumann Kreuziger","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.11.017_bib20","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.3109\/10428194.2014.982640","article-title":"Treatment of catheter-related deep vein thrombosis in patients with acute leukemia with anticoagulation","volume":"56","author":"Oliver","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtha.2023.11.017_bib21","first-page":"E368","article-title":"Central venous catheter (CVC)-related thrombosis (CRT) in leukemia patients with severe thrombocytopenia: a retrospective analysis","volume":"91","author":"Samuelson","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2023.11.017_bib22","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1016\/j.clinthera.2017.07.041","article-title":"Rivaroxaban in the treatment of PICC-associated upper extremity venous thrombosis","volume":"39","author":"Fan","year":"2017","journal-title":"Clin Ther"},{"key":"10.1016\/j.jtha.2023.11.017_bib23","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1002\/ajh.24588","article-title":"Treatment of central venous catheter-associated deep venous thrombosis in cancer patients with rivaroxaban","volume":"92","author":"Laube","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2023.11.017_bib24","first-page":"130","article-title":"Clinical outcomes of catheter-associated venous thrombosis in the post-hematopoietic stem cell transplant setting","author":"Moyer","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.11.017_bib25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.thromres.2017.04.003","article-title":"A\u00a0prospective study of Rivaroxaban for central venous catheter associated upper extremity deep vein thrombosis in cancer patients (Catheter 2)","volume":"162","author":"Davies","year":"2018","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.11.017_bib26","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1007\/s11239-018-1711-5","article-title":"Incidence and outcomes of catheter related thrombosis (CRT) in patients with acute leukemia using a platelet-adjusted low molecular weight heparin regimen","volume":"46","author":"Htun","year":"2018","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2023.11.017_bib27","article-title":"Catheter-associated upper extremities deep vein thrombosis in cancer patients: does anticoagulation time matter","volume":"4","author":"Dalla Salda","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.11.017_bib28","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s11239-020-02040-8","article-title":"PICC-related upper deep venous thrombosis in patients with hematological malignancies. Management of anticoagulant therapy according to the platelet count","volume":"49","author":"Scamuffa","year":"2020","journal-title":"J\u00a0Thromb Thrombolysis"},{"key":"10.1016\/j.jtha.2023.11.017_bib29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.thromres.2021.03.021","article-title":"Treatment of catheter-related thrombosis in patients with hematologic malignancies: a Venous thromboEmbolism Network U.S. retrospective cohort study","volume":"202","author":"Baumann Kreuziger","year":"2021","journal-title":"Thromb Res"},{"issue":"SUPPL 2","key":"10.1016\/j.jtha.2023.11.017_bib30","article-title":"The use of DOACs in catheter related thrombosis in cancer","volume":"5","author":"Faruqi","year":"2021","journal-title":"Research and Practice in Thrombosis and Haemostasis"},{"key":"10.1016\/j.jtha.2023.11.017_bib31","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1182\/blood-2022-159135","article-title":"A\u00a0prospective study of apixaban for central venous catheter associated upper extremity deep vein thrombosis in cancer patients: Catheter 3","volume":"140","author":"Kovacs","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.11.017_bib32","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.880698","article-title":"A\u00a0Single center retrospective cohort study comparing different anticoagulants for the treatment of catheter-related thrombosis of the upper extremities in women with gynecologic and breast cancer","volume":"9","author":"Porfidia","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jtha.2023.11.017_bib33","article-title":"Venous thrombosis recurrence after catheter-related upper extremity deep venous thrombosis in cancer patients: a retrospective analysis","author":"Hakem","year":"2023","journal-title":"Angiology"},{"key":"10.1016\/j.jtha.2023.11.017_bib34","first-page":"E59","article-title":"Safety of direct oral anticoagulants (DOACs) vs standard of care (SOC) in cancer patients with catheter associated venous thromboembolism","volume":"98","author":"Kulasekaran","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2023.11.017_bib35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12959-023-00456-9","article-title":"Efficacy and safety of rivaroxaban for the treatment of PICC-related upper extremity deep vein thrombosis in cancer patients: a retrospective study","volume":"21","author":"Xu","year":"2023","journal-title":"Thromb J"},{"key":"10.1016\/j.jtha.2023.11.017_bib36","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.293.6.715","article-title":"Malignancies, prothrombotic mutations, and the risk of venous thrombosis","volume":"293","author":"Blom","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2023.11.017_bib37","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.chest.2021.09.037","article-title":"Rivaroxaban vs dalteparin in cancer-associated thromboembolism: a randomized trial","volume":"161","author":"Planquette","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2023.11.017_bib38","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.avsg.2011.12.016","article-title":"Low incidence of pulmonary embolism associated with upper-extremity deep venous thrombosis","volume":"26","author":"Levy","year":"2012","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.jtha.2023.11.017_bib39","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.thromres.2015.08.020","article-title":"Systematic review of anticoagulant treatment of catheter-related thrombosis","volume":"136","author":"Baumann Kreuziger","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2023.11.017_bib40","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2023.11.017_bib41","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO clinical practice guideline update","volume":"38","author":"Key","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jtha.2023.11.017_bib42","unstructured":"Cancer-Associated Venous Thromboembolic Disease, Version 2.2021, NCCN guideline panel. 2021."},{"key":"10.1016\/j.jtha.2023.11.017_bib43","doi-asserted-by":"crossref","first-page":"e566","DOI":"10.1016\/S1470-2045(19)30336-5","article-title":"Douketis J, the International Initiative on Thrombosis and Cancer (ITAC) advisory panel. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer","volume":"20","author":"Farge","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jtha.2023.11.017_bib44","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/1469-0691.12494","article-title":"The effects of clinical and statistical heterogeneity on the predictive values of results from meta-analyses","volume":"20","author":"Melsen","year":"2014","journal-title":"Clin Microbiol Infect"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623008553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623008553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:39:53Z","timestamp":1761536393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783623008553"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S1538783623008553"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2023.11.017","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of catheter-related upper extremity deep vein thrombosis in patients with cancer: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2023.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}